Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

512 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.
Dubsky P, Curigliano G, Burstein HJ, Winer EP, Gnant M, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B; Panel Members of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017; André F, Baselga J, Bergh J, Bonnefoi H, Brucker SY, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Khaled H, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B. Dubsky P, et al. Among authors: colleoni m. Ann Oncol. 2018 Jan 1;29(1):281-282. doi: 10.1093/annonc/mdx543. Ann Oncol. 2018. PMID: 29045519 Free PMC article. No abstract available.
Pre-operative chemotherapy and radiotherapy in breast cancer.
Colleoni M, Nole F, Minchella I, Noberasco C, Luini A, Orecchia R, Veronesi P, Zurrida S, Viale G, Goldhirsch A. Colleoni M, et al. Eur J Cancer. 1998 Apr;34(5):641-5. doi: 10.1016/s0959-8049(97)10091-0. Eur J Cancer. 1998. PMID: 9713267
Assessment of response in primary chemotherapy for breast cancer.
Colleoni M, Orlando L, Robertson C, Nolé F, Peruzzotti G, Cassano R, Orvieto E, Viale G, Goldhirsch A. Colleoni M, et al. Ann Oncol. 1998 Oct;9(10):1140-1. doi: 10.1023/a:1008425205941. Ann Oncol. 1998. PMID: 9834831 Free article. No abstract available.
Prediction of response to primary chemotherapy for operable breast cancer.
Colleoni M, Orvieto E, Nolé F, Orlando L, Minchella I, Viale G, Peruzzotti G, Robertson C, Noberasco C, Galimberti V, Sacchini V, Veronesi P, Zurrida S, Orecchia R, Goldhirsch A. Colleoni M, et al. Eur J Cancer. 1999 Apr;35(4):574-9. doi: 10.1016/s0959-8049(99)00005-2. Eur J Cancer. 1999. PMID: 10492630
Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN).
Nolè F, Minchella I, Colleoni M, Orvieto E, Munzone E, de Braud F, Peruzzotti G, Martinelli G, Zampino MG, Catania C, Pizzamiglio M, Veronesi P, Zurrida S, Galimberti V, Goldhirsch A, Veronesi U. Nolè F, et al. Among authors: colleoni m. Ann Oncol. 1999 Aug;10(8):993-6. doi: 10.1023/a:1008389106575. Ann Oncol. 1999. PMID: 10509165 Free article. Clinical Trial.
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group.
Colleoni M, Bonetti M, Coates AS, Castiglione-Gertsch M, Gelber RD, Price K, Rudenstam CM, Lindtner J, Collins J, Thürlimann B, Holmberg S, Veronesi A, Marini G, Goldhirsch A. Colleoni M, et al. J Clin Oncol. 2000 Feb;18(3):584-90. doi: 10.1200/JCO.2000.18.3.584. J Clin Oncol. 2000. PMID: 10653873
Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required?
Orlando L, Colleoni M, Nolè F, Biffi R, Rocca A, Curigliano G, Ferretti G, Peruzzotti G, de Braud F, Masci G, Goldhirsch A. Orlando L, et al. Among authors: colleoni m. Ann Oncol. 2000 Jan;11(1):117-8. doi: 10.1023/a:1008364801718. Ann Oncol. 2000. PMID: 10690401 Free article. No abstract available.
512 results